Grifols, S.A. (Grifols) is a pharmaceutical and chemical company focused at improving the health and well being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, diagnostic products and hospital pharmacy products. It produces plasma derived protein therapies for patients suffering with rare, genetic diseases and life-threatening infections. Grifols has plasma donation centers across the US and industrial facilities in Australia, Mexico, Switzerland, the US and Spain. It established a system that carries out operations from collecting source plasma to the fractionation, purification and production of the finished product. Grifols is headquartered in Sant Cugat del Valles, Barcelona, Spain.